요약정보
Prognostic gene expression signature for high-grade serous ovarian cancer.
- Resource Type
- Academic Journal
- Authors
- Millstein J; Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.; Budden T; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, Australia; CRUK Manchester Institute, The University of Manchester, Manchester, UK.; Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, USA.; Anglesio MS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Talhouk A; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Intermaggio MP; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, Australia.; Leong HS; Peter MacCallum Cancer Center, Melbourne, Australia.; Chen S; Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.; Elatre W; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, USA.; Gilks B; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.; Nazeran T; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Volchek M; Anatomical Pathology, Royal Women's Hospital, Parkville, Australia.; Bentley RC; Department of Pathology, Duke University Hospital, Durham, USA.; Wang C; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, USA.; Chiu DS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.; Leung SCY; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Senz J; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.; Lum A; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Chow V; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Sudderuddin H; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; Mackenzie R; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.; George J; The Jackson Laboratory for Genomic Medicine, Farmington, USA.; Fereday S; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Hendley J; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Traficante N; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Steed H; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Royal Alexandra Hospital, Edmonton, Canada.; Koziak JM; Alberta Health Services-Cancer Care, Calgary, Canada.; Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, Canada.; McNeish IA; Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Ennis D; Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Silva De Silva D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Ramón Y Cajal T; Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain.; García-Donas J; HM Hospitales D Centro Integral Oncológico HM Clara Campal, Madrid, Spain.; Hernando Polo S; Medical Oncology Service, Hospital Universitario Funcacion Alcorcon, Alcorcón, Spain.; Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, USA.; Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA.; Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA; Department of Epidemiology, University of Washington, Seattle, USA.; Greene CS; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.; Zelaya RA; Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, USA.; Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sinn P; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Herpel E; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.; Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, USA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.; Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Oszurek O; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Tołoczko A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Menkiszak J; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.; Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, USA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA.; Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA.; Tseng C; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.; Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Song H; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Jimenez-Linan M; Department of Pathology, Addenbrooke's Hospital NHS Trust, Cambridge, UK.; Piskorz AM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.; Karpinskyj C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.; Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.; Singh N; Department of Pathology, Barts Health National Health Service Trust, London, UK.; Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Sharma R; Pathology West ICPMR Westmead, Westmead Hospital, The University of Sydney, Sydney, Australia; University of Western Sydney at Westmead Hospital, Sydney, Australia.; Harnett PR; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; The Crown Princess Mary Cancer Centre Westmead, Sydney-West Cancer Network, Westmead Hospital, Sydney, Australia.; Gao B; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; The Crown Princess Mary Cancer Centre Westmead, Sydney-West Cancer Network, Westmead Hospital, Sydney, Australia.; Johnatty SE; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Sayer R; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Boros J; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Winham SJ; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, USA.; Keeney GL; Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, USA.; Kaufmann SH; Department of Oncology, Mayo Clinic, Rochester, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, USA.; Larson MC; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, USA.; Luk H; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.; Hernandez BY; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.; Thompson PJ; Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, USA.; Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, USA.; Carney ME; John A. Burns School of Medicine, Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, USA.; Trabert B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.; Lissowska J; Department of Cancer Epidemiology and Prevention, M Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.; Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.; Sherman ME; Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, USA.; Bodelon C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.; Hinsley S; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Lewsley LA; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Glasspool R; Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.; Banerjee SN; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.; Stronach EA; Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK.; Haluska P; Department of Oncology, Mayo Clinic, Rochester, USA.; Ray-Coquard I; Centre Leon Berard and University Claude Bernard Lyon 1, Lyon, France.; Mahner S; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.; Winterhoff B; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, USA.; Slamon D; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, USA.; Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA; Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, USA.; Kelemen LE; Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, Charleston, USA.; Benitez J; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.; Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.; Goodman MT; Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, USA.; Schildkraut JM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA.; Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.; Brown R; Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.; Berchuck A; Department of Gynecologic Oncology, Duke University Hospital, Durham, USA.; Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; deFazio A; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, USA.; García MJ; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.; Henderson MJ; Children's Cancer Institute, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, Australia.; Rossing MA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA; Department of Epidemiology, University of Washington, Seattle, USA.; Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, USA.; Fasching PA; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, USA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; Orsulic S; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, USA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.; Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, USA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.; Konecny GE; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, USA.; Huntsman DG; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada.; Bowtell DD; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Doherty JA; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, USA.; Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Ramus SJ; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, Australia; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, Australia. Electronic address: s.ramus@unsw.edu.au.
- Source
- Publisher:
Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN:09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE - Subject
- Language
- English